Variants were found in 73% (8/11) of patients with MDS, 71% (5/7) of patients with GATA2 deficiency related bone marrow and immunodeficiency disorder (G2BMID), and only in one subject with normal blood cells count and bone marrow histology. Here, GATA2 is linked to myelodysplastic syndrome.